Skip to main content

Torley Helen's Form 4 filing

Halozyme Therapeutics, Inc. (HALO) · filed Aug 15, 2024

Accession no.
0001415889-24-021370
Filed
Aug 15, 2024
Trade date
Aug 13-15, 2024
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 8 non-derivative transactions and 3 derivative transactions. Open-market sales total $1.71M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Torley HelenCIK 0001528185Director, Officer (PRESIDENT AND CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 13, 2024Common StockMOption exerciseAcquired+10,000$13.87+$138,700686,744Direct
Aug 13, 2024Common StockSSaleDisposed−10,000$56.25−$562,500676,744Direct
Aug 14, 2024Common StockMOption exerciseAcquired+10,000$13.87+$138,700686,744Direct
Aug 14, 2024Common StockSSaleDisposed−3,263$56.22−$183,445.86683,481Direct
Aug 14, 2024Common StockSSaleDisposed−6,537$57.73−$377,381.01676,944Direct
Aug 14, 2024Common StockSSaleDisposed−200$58.17−$11,634676,744Direct
Aug 15, 2024Common StockMOption exerciseAcquired+10,000$13.87+$138,700686,744Direct
Aug 15, 2024Common StockSSaleDisposed−10,000$57.95−$579,500676,744Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 13, 2024Common StockMOption exerciseDisposed−10,000$13.87−$138,700100,000Direct
Aug 14, 2024Common StockMOption exerciseDisposed−10,000$13.87−$138,70090,000Direct
Aug 15, 2024Common StockMOption exerciseDisposed−10,000$13.87−$138,70080,000Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)